| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |